Abstract
Dopamine (DA) and 3,4-dihydroxy-l-phenylalanine (L-Dopa or DPA), a marker and medicine for the neurological disorder Parkinson's disease (PD), lead to the formation of polymeric fluorescent nanoparticles (F-Poly NPs or F-NPs or simply, NPs). The interaction study between proteins and NPs shows prominent interaction with strong specificity toward albumin type proteins for DPA derived and mixed NPs. Furthermore, encapsulation of the anticancer drug doxorubicin hydrochloride (Dox) inside the NP-protein conjugates results in excellent white light emission with pronounced specificity toward albumin proteins for F-PDPA and F-Mix NPs. Finally, the use of BSA protein fibril resulting in strong binding with NPs along with Dox assisted white light emission has also been studied.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
